Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-001184
Filing Date
2022-02-09
Accepted
2022-02-09 17:03:59
Documents
1
Period of Report
2022-02-07

Document Format Files

Seq Description Document Type Size
1 form4-02092022_020249.html 4  
1 form4-02092022_020249.xml 4 3152
  Complete submission text file 0001415889-22-001184.txt   4518
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
PITZER KENNETH R (Reporting) CIK: 0001668775 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 22608072